CN106166176A - A kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin - Google Patents

A kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin Download PDF

Info

Publication number
CN106166176A
CN106166176A CN201610704060.0A CN201610704060A CN106166176A CN 106166176 A CN106166176 A CN 106166176A CN 201610704060 A CN201610704060 A CN 201610704060A CN 106166176 A CN106166176 A CN 106166176A
Authority
CN
China
Prior art keywords
fosfomycin
cortex cinnamomi
compound medicine
poultry
poultry compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610704060.0A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University
Original Assignee
Guangxi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University filed Critical Guangxi University
Priority to CN201610704060.0A priority Critical patent/CN106166176A/en
Publication of CN106166176A publication Critical patent/CN106166176A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin, be made up of fosfomycin and Cortex Cinnamomi, the weight ratio of fosfomycin and Cortex Cinnamomi is 1:10 1:30.The present invention is also claimed by the compound preparation become prepared by above-mentioned poultry compound medicine.The present invention possesses and provides the benefit that: proving through experimental study, fosfomycin is used in combination with specific part by weight with Cortex Cinnamomi, has synergism obvious, and curative effect is fast, low cost and other advantages.

Description

A kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin
Technical field
The invention belongs to poultry compound medicine technical field, particularly relate to a kind of poultry containing Cortex Cinnamomi and fosfomycin with multiple Side's medicine, the disease caused for treating poultry to be infected by colon bacillus.
Background technology
After poultry are infected by colon bacillus, the multiple locations such as acute sepsis, peritonitis, hepatitis, pneumonia, enteritis can be caused Severe infections, causes huge economic loss to livestock and poultry cultivation.Fosfomycin, norfloxacin, florfenicol etc. are to prevent and treat this type of disease Sick conventional Western medicine, along with medication is more and more spread unchecked, its Resistant strain is the most, and drug cost is the most increasing, but controls Therapeutic effect and drug resistance situation are not taken a turn for the better, and go from bad to worse on the contrary.
Through retrieval, do not inquire Cortex Cinnamomi and fosfomycin are combined for treat poultry by colon bacillus infect cause The relevant report of disease.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin, and it is worked in coordination with Effect is substantially, it is possible to eliminate the colon bacillus drug resistance to fosfomycin, improves therapeutic effect.
For solving above technical problem, the present invention by the following technical solutions: a kind of poultry containing Cortex Cinnamomi and fosfomycin are used Compound medicine, is made up of fosfomycin and Cortex Cinnamomi, and the weight ratio of fosfomycin and Cortex Cinnamomi is 1:10-1:30.
The present invention is also claimed by the compound preparation become prepared by above-mentioned poultry compound medicine.
The present invention possesses and provides the benefit that: proving through experimental study, fosfomycin joins with specific part by weight with Cortex Cinnamomi Closing and use, have synergism obvious, curative effect is fast, low cost and other advantages.
Detailed description of the invention
Below in conjunction with specific embodiment, technical scheme and beneficial effect are described further, except Special Statement Outward, Cortex Cinnamomi weight of the present invention is the dry weight of Cortex Cinnamomi.
One, the Cortex Cinnamomi mensuration to the drug resistance elimination effect of fosfomycin
1. assay method
It is the mixing medicine that 1:1,1:3,1:5,1:10,1:30,1:50 prepare Cortex Cinnamomi and various Western medicine respectively according to weight ratio Liquid;Choose the bacterial strain to Western medicine drug resistance as subjects, utilize plate dilution method to carry out Secondary Culture, measure each process medicinal liquid MIC situation of change to Resistant strain;Set the Western medicine being not added with Cortex Cinnamomi to compare as sun, if it is right as the moon to be not added with Cortex Cinnamomi and Western medicine simultaneously According to.
Above-mentioned process was cultivated for 4 generations the most continuously.
2. result of the test
After cultivating for 4 generations continuously, the process flat board of cloudy comparison is long bacterium, and other each medicaments and admixing medical solutions are for large intestine angstrom The result statistics of the MIC (μ g/mL) of uncommon Salmonella is as shown in table 1:
As seen from the above table, when the weight ratio of fosfomycin Yu Cortex Cinnamomi is 1:10 and 1:30, drug resistance large intestine angstrom is wished by fosfomycin The minimal inhibitory concentration of Salmonella reduces 16 times and more than 32 times respectively, it is seen then that the drug resistance colon bacillus drug resistance to fosfomycin Property substantially reduces.
And when fosfomycin and Cortex Cinnamomi are other weight ratios, the fosfomycin minimal inhibitory concentration to drug resistance colon bacillus Compared with the sun comparison being not added with Cortex Cinnamomi, there is no significant change.
Two, the experiment in vitro that fosfomycin and Cortex Cinnamomi are used in combination
It is 1:10 mixing by fosfomycin and Cortex Cinnamomi (powder) according to weight ratio, makes powder, as test group;Separately set fosfomycin Single dose and Cortex Cinnamomi single dose as a control group 1 and matched group 2.
Subjects is the chicken group making a definite diagnosis and having infected E.coli from chickens disease.
Morbidity chicken group is divided into 3 groups of administrations.Test group is administered according to the addition of 12g/kg feedstuff, and matched group 1 is mould with phosphorus Element single dose is administered according to the addition of 1g/kg feedstuff, and matched group 2 Cortex Cinnamomi single dose is administered according to the addition of 12g/kg feedstuff; The equal SM of each group 5 days.
Result of the test: the sick chicken feed intake of test group increased, without dead, after using 5 days, chicken group can fully recover;Comparison Chicken group's great majority still wan of group 1, has the sick chicken death of 4%;Chicken group's great majority of matched group 2 are also still wans, have 7% Sick chicken death.

Claims (2)

1. one kind contains Cortex Cinnamomi and the poultry compound medicine of fosfomycin, it is characterised in that be made up of fosfomycin and Cortex Cinnamomi, fosfomycin It is 1:10-1:30 with the weight ratio of Cortex Cinnamomi.
2. by the compound preparation become prepared by the poultry compound medicine described in claim 1.
CN201610704060.0A 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin Withdrawn CN106166176A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610704060.0A CN106166176A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610704060.0A CN106166176A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin

Publications (1)

Publication Number Publication Date
CN106166176A true CN106166176A (en) 2016-11-30

Family

ID=57376620

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610704060.0A Withdrawn CN106166176A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin

Country Status (1)

Country Link
CN (1) CN106166176A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103977089A (en) * 2014-05-14 2014-08-13 广西大学 Compound medicine containing radix paeoniae rubrathe and phosphonomycin used for livestock and poultry
CN104337847A (en) * 2014-11-12 2015-02-11 中国农业科学院哈尔滨兽医研究所 Compound medicine containing bracken and fosfomycin for livestock
CN104435040A (en) * 2014-11-07 2015-03-25 广西大学 Balsamiferou blumea herb and fosfomycin containing compound medicine for livestock and poultry

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103977089A (en) * 2014-05-14 2014-08-13 广西大学 Compound medicine containing radix paeoniae rubrathe and phosphonomycin used for livestock and poultry
CN104435040A (en) * 2014-11-07 2015-03-25 广西大学 Balsamiferou blumea herb and fosfomycin containing compound medicine for livestock and poultry
CN104337847A (en) * 2014-11-12 2015-02-11 中国农业科学院哈尔滨兽医研究所 Compound medicine containing bracken and fosfomycin for livestock

Similar Documents

Publication Publication Date Title
CN106138318A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and amoxicillin
CN106176897A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and LIJUNJING
CN106109638A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and LIJUNJING
CN106109549A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and norfloxacin
CN106138320A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and norfloxacin
CN106166176A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin
CN106176943A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and LIJUNJING
CN106109547A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and fosfomycin
CN106139121A (en) A kind of poultry compound medicine containing Cortex Cinnamomi, Fructus Rosae Laevigatae and colistin
CN106109578A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and amoxicillin
CN106176895A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and amoxicillin
CN106176941A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and florfenicol
CN106214742A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and ceftiofur sodium
CN106267152A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and colistin
CN106176942A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and norfloxacin
CN106109577A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium
CN106109548A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and florfenicol
CN106267153A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and colistin
CN106177904A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and colistin
CN106138319A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and florfenicol
CN106176944A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and amikacin
CN106176896A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and amikacin
CN106236879A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium
CN106166184A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and amikacin
CN106266049A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and sulfamonomethoxine sodium

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20161130

WW01 Invention patent application withdrawn after publication